Skip to content
Review

The recognition, diagnosis, and management of late-onset bipolar disorder

Aug 2026 · Expert Review of Neurotherapeutics · Vol 26, pp. 971 - 983 · 0 citations · 83 references
Medicine

TL;DR

Current evidence suggests that LOBD likely represents a heterogeneous condition with multiple underlying mechanisms, including vascular burden, neurodegenerative processes, and age-related biological vulnerability, including vascular burden, neurodegenerative processes, and age-related biological vulnerability.

Abstract

ABSTRACT Introduction Late-onset bipolar disorder (LOBD) represents a clinically relevant but understudied subtype of bipolar. Compared with early-onset bipolar disorder, LOBD may present with distinct clinical features, increased somatic comorbidity, and potential associations with neurodegenerative and vascular processes. Specific diagnostic and therapeutic recommendations for LOBD are currently limited. Areas covered This narrative review examines the current evidence regarding epidemiology, pathophysiology, diagnostic workup, and management of LOBD. Literature was identified using PubMed to conduct a structured literature search of the MEDLINE database for articles between 2015 and 2025, and review of relevant articles. Particular attention is given to differential diagnosis with secondary mania and neurodegenerative disorders, the role of medical and neurological evaluation, and treatment considerations including pharmacological strategies, neuromodulation, psychosocial interventions, and longitudinal follow-up. Expert opinion Current evidence suggests that LOBD likely represents a heterogeneous condition with multiple underlying mechanisms, including vascular burden, neurodegenerative processes, and age-related biological vulnerability. Comprehensive somatic and cognitive assessment is essential. While treatment generally follows established bipolar disorder guidelines, careful adaptation is required due to comorbidity, polypharmacy, and age-related pharmacodynamic changes. Lithium, with its potential neuroprotective properties, may be the first-choice medication. Future research should focus on clarifying pathophysiological mechanisms and developing tailored management strategies.

View source

Similar papers

Review Open access Aug 2026

Bipolar Disorder in Older Adults: Clinical Presentation, Challenges, and Management Strategy

This review examines epidemiology, clinical features, diagnostic challenges, and treatment strategies for older adults with bipolar disorder, requiring a balance between evidence-based pharmacological treatments, psychosocial support, and careful attention to comorbidities and functional status.

Michel Bourin · 0 citations
Review Open access Aug 2026

Exploring and understanding delirium: a comprehensive narrative review with emphasis on neurological disorders

An updated overview of delirium is provided, emphasizing its complex pathophysiology, clinical characteristics, risk factors, diagnostic challenges, and management strategies, particularly in patients with neurological disorders.

Arpan Mitra, N. Srivastava, Ankur Vivek et al. · 0 citations
Review Sep 2026

Pediatric multiple sclerosis: a diagnostic overview and the importance of early identification

This review summarizes the diagnostic work-up of children with a first acquired demyelinating syndrome, differential diagnosis, the role of MRI, cerebrospinal fluid (CSF) markers, antibody testing, serum neurofilament light chain, optical pathway assessment and the 2024 McDonald criteria.

M. Margoni, Massimo Filippi, M. Rocca · 0 citations
Review Open access Sep 2026

Distinguishing bipolar disorder from unipolar depression in general practice: A systematic review

Abstract Objective Bipolar disorder affects approximately 1% of the population, although some studies report prevalence rates of up to 6%. Distinguishing it from unipolar depression remains challenging, with diagnostic delays often exceeding ten years. This systematic review aims to identify clinical and historical fea...

Docteur Scheherazade Niktabe, Catherine Massoubre · 0 citations
Review Open access Sep 2026

The complexities of diagnosing young-onset Alzheimer’s dementia and the need for swift identification

YOAD remains underrecognized and diagnostically challenging, limiting timely access to targeted therapies and the integration of multimodal biomarkers and genetic testing is essential for early diagnosis, as is the need for a comprehensive neuropsychological assessment to capture atypical phenotypes.

A. Schild, C. Bartels, R. Dodel · 0 citations
Open access Aug 2026

Bipolar spectrum disorders in apparent treatment-resistant depression: diagnostic pitfalls and implications for contemporary psychiatric practice

Patients referred with apparent treatment-resistant depression (TRD) are a diagnostically heterogeneous group. A clinically important minority have unrecognised bipolar spectrum disorders (BSD), most commonly bipolar II disorder, cyclothymic disorder or depressive episodes with mixed features. Misclassification may r...

M. Al Alawi, A. Al Ghailani, A. Al Harrasi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.